about
Global health 2035: a world converging within a generationEconomic evaluation of pneumococcal conjugate vaccination in The GambiaA model-based estimate of cumulative excess mortality in survivors of childhood cancerCost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesThe costs of reducing loss to follow-up in South African cervical cancer screening.Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United StatesPatient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.Taking account of future technology in cost effectiveness analysisPackaging health services when resources are limited: the example of a cervical cancer screening visit.The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in MexicoMathematical models of cervical cancer prevention in the Asia Pacific region.Cost-effectiveness of Rotavirus vaccination in VietnamProgram spending to increase adherence: South African cervical cancer screeningThe cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysisHealth and economic impact of rotavirus vaccination in GAVI-eligible countriesA health services research agenda for cellular, molecular and genomic technologies in cancer care.Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico.Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.Assessing the performance of a computer-based policy model of HIV and AIDSCost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment.Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria.Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation modelHealth and economic implications of HPV vaccination in the United States.Empirically calibrated model of hepatitis C virus infection in the United States.Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.Health economics and cervical cancer prevention: a global perspective.Use of visual screening methods for cervical cancer screening.Estimating the cost of cervical cancer screening in five developing countriesCost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosisChapter 15: Public health policy and cost-effectiveness analysis.A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessModel-based analyses to compare health and economic outcomes of cancer control: inclusion of disparitiesEffects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA testsInterim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.When does quality-adjusting life-years matter in cost-effectiveness analysis?Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.
P50
Q21034164-E7C02A3A-BB81-473F-9197-C338A29799D2Q21261836-B83DBEFE-0ECB-4F60-B203-E2DFE8A8CB9DQ24602917-56172DB2-8C4D-4495-A9BA-30F7D157243DQ24655328-6564B39A-ED74-4AFD-BDA4-AE78343A83FCQ24815385-E67DC885-5157-43B0-8ABD-6F1F46FFF4A3Q25256680-A2D2622C-6469-4483-85ED-96D9684DBDCDQ30528513-DECE7EE4-428A-4445-A1EC-5C39B1A80EF4Q30833185-88EDF9E5-C221-40B1-BCAF-912926200365Q33263573-9782CB92-0A0F-4999-9F43-FD2402ADF607Q33294721-A6A1298C-42A1-4A60-88FF-B6E79D43A6BBQ33378841-CCA4AF6F-D760-4C26-9171-AA084D22AD30Q33401714-C1523171-437A-4466-9E19-64F3D0042F9FQ33459276-D024CEBC-5CA9-4D94-9441-F90703E7DED9Q33559823-5B6A4F19-9AD4-48C0-8FA2-1B180F834717Q33565320-7C78E7E5-16F5-4F1C-927D-A22DEE905245Q33578406-D1EA6D0E-AA43-4546-B3E4-203052E57291Q33749983-32E3AD14-3FC8-4CE0-BD50-CDF910365511Q33778610-56C3C2D0-60C9-44D8-AAD3-342B5C2AF265Q33934529-36F1E3BE-9FAA-480B-B918-64C91D8B1E1FQ33998494-8D5D60DE-2040-4A61-9A24-54E85CA6A0A7Q34115343-21816140-0BFB-40E8-98A4-17058E30B11AQ34157164-2C219117-E9BF-4D73-B3E0-EBBB7E0D6916Q34328306-49022995-7DA6-44F3-977C-51CEF3E52DF3Q34414815-DC0E456E-03E7-43B2-91AC-3DAC4B64E9BFQ34734891-0B250174-FD2A-4109-BF42-7C40DC6D9417Q34824304-F1520D49-0A90-4D3C-9ABF-B3E98A48BC5CQ34948964-A0606300-0E18-48D5-9911-E1A23BA20849Q34997604-FD393960-4C32-435F-943F-201AB7D2765AQ35006204-6743B689-9582-473E-93CE-F11032A59A3AQ35037345-AC5C0001-99D8-480B-8C89-FCF16C20ED24Q35039416-9EC22EA1-9225-4EB2-9FE2-BF2C94025C3AQ35122619-3D7DD9FA-F154-45C3-95B4-E9C32F644AA9Q35154963-50F7F080-80CD-4B17-A186-C5C9C6DF3542Q35199478-690723EE-9FF3-487B-88F1-4776E99E09FDQ35217495-54538874-B583-4D9A-8156-1E0CF9D7E1F1Q35223397-F06129A7-814E-400E-8D39-C6404302F1D8Q35508095-D09D5B49-E08D-4083-B1F8-CC0FCFF8BC41Q35644704-F5B6EA2B-B2F5-4597-866C-BBC84377A680Q35764637-FB4CB2E4-61A8-4EEE-A31B-05B339B33BA0Q35858737-F0B8626A-7FAC-46FC-9BD0-9B3420CF67DB
P50
description
American academic
@en
académica estadounidense
@es
onderwijzer
@nl
name
Sue Goldie
@ast
Sue Goldie
@de
Sue Goldie
@en
Sue Goldie
@es
Sue Goldie
@fr
Sue Goldie
@it
Sue Goldie
@nl
type
label
Sue Goldie
@ast
Sue Goldie
@de
Sue Goldie
@en
Sue Goldie
@es
Sue Goldie
@fr
Sue Goldie
@it
Sue Goldie
@nl
prefLabel
Sue Goldie
@ast
Sue Goldie
@de
Sue Goldie
@en
Sue Goldie
@es
Sue Goldie
@fr
Sue Goldie
@it
Sue Goldie
@nl
P69
P106
P21
P31
P569
1962-01-01T00:00:00Z
P735
P7578
sue-goldie